Back to Search
Start Over
ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm.
- Source :
- Circulation; 12/2/2014, Vol. 130 Issue 23, p2108-2109, 2p
- Publication Year :
- 2014
Details
- Language :
- English
- ISSN :
- 00097322
- Volume :
- 130
- Issue :
- 23
- Database :
- Complementary Index
- Journal :
- Circulation
- Publication Type :
- Academic Journal
- Accession number :
- 99910952